LH supplementation in assisted reproductive technology cycles improves the ongoing pregnancy rate in women with poor ovarian response (POR). However, our knowledge of the precise role of LH during the follicular phase of the menstrual cycle is incomplete. To explore the role of LH in the maturation of small antral follicles, we used an in vitro two-cell system that involved coculturing bovine granulosa cells (GCs) and theca cells (TCs) on a collagen membrane. Treatment of TCs with LH stimulated androgen production in TCs by inducing the expression of androgenic factors, subsequently increasing estrogen biosynthesis in GCs by providing androgen substrates, and inducing aromatase expression. LH stimulation of TCs induced functional LH receptor expression in GCs, a response modulated by the synthesis and action of estrogen. In the presence of TCs, LH stimulation of TCs and FSH stimulation of GCs increased the expression of IGF-1, IGF-2, and IGF-1 receptor in GCs. LH-induced expression of thecal IGF-1 protected GCs from apoptosis and promoted GC survival. Furthermore, LH stimulation of TCs increased FSH sensitivity in GCs. Thus, the LH-TC axis may be involved in the acquisition of LH dependence and the survival of small antral follicles by upregulating androgen/estrogen biosynthesis and activating the IGF system. The use of LH supplementation in ovarian stimulation may increase gonadotropin sensitivity in small antral follicles and promote follicular growth and survival by suppressing GC apoptosis and follicular atresia, resulting in multiple follicular development, even in patients with POR. (Endocrinology 159: 2337(Endocrinology 159: -2347(Endocrinology 159: , 2018 C ontrolled ovarian stimulation (COS) is an integral part of assisted reproductive technology (ART) because the success of ART depends, in part, on obtaining a sufficient number of healthy eggs to create high-quality embryos. Poor ovarian response (POR) is a common clinical problem, with 9% to 26% of ART cycles resulting in poor response to COS (1-3). Various COS protocols have been attempted for women with POR, but success rates remain low.
C ontrolled ovarian stimulation (COS) is an integral part of assisted reproductive technology (ART) because the success of ART depends, in part, on obtaining a sufficient number of healthy eggs to create high-quality embryos. Poor ovarian response (POR) is a common clinical problem, with 9% to 26% of ART cycles resulting in poor response to COS (1) (2) (3) . Various COS protocols have been attempted for women with POR, but success rates remain low.
FSH plays a central role in the regulation of follicle recruitment and growth, whereas LH is mandatory for further follicular growth (beyond 10 mm in diameter) and estradiol (E2) production (4, 5) . The current concept suggests that the follicular phase can be divided into (1) the FSH-dependent follicular growth phase and (2) the LH-dependent follicular maturation phase (6) . A recent Cochrane review (7) showed that, in women with POR, the use of recombinant LH (rLH) combined with recombinant FSH (rFSH) leads to more ongoing pregnancies than rFSH alone, suggesting a beneficial effect of LH on follicle growth in patients with POR.
Basic and clinical evidence has indicated that a threshold of LH stimulation is required for adequate follicular development and oocyte maturation (8) (9) (10) (11) . In the human menstrual cycle, LH concentrations rarely fall lower than 2 IU/L in the follicular phase, and normally range from 2 to 5 IU/L (11) . Conversely, in gonadotropin-releasing hormone (GnRH) antagonist or long-protocol GnRH agonist cycles, LH concentrations fall lower than 1 IU/L, which characterizes hypogonadotropic hypogonadism (12, 13) . Whether LH supplementation is necessary for normogonadotropic women undergoing pituitary suppression with GnRH analog is still the subject of debate. Nevertheless, evidence indicates that severely suppressed, midfollicular, serum LH concentrations are associated with poor reproductive outcomes (11, 14) . These findings provide some indirect evidence that the addition of LH may be clinically beneficial in patients with deeply suppressed LH concentrations after pituitary downregulation with GnRH analog.
In humans, LH receptor (LHR) expression is not restricted to large preovulatory follicles but occurs in granulosa cells (GCs) from small antral follicles (5 to 6 mm in diameter), suggesting that LH may affect follicular development at earlier stages than previously considered (15) . Better ongoing pregnancy rates are observed when rLH administration is started on the first day of COS, suggesting that LH stimulates the growth and maturation of small antral follicles from the early follicular phase (16) . Nevertheless, our knowledge of the precise role of LH during the follicular phase of the menstrual cycle is incomplete. Thus, this study was designed to elucidate the role of LH in antral follicular development during the follicular phase.
In monovulatory species such as cattle and humans, the tetralogy of final follicular maturation involves (1) greater capacity for E2 production, (2) activation of the IGF system, (3) acquisition of LH dependence, and (4) an antiapoptotic follicular microenvironment (17) (18) (19) (20) (21) . In the current study, we examined whether and how LH regulates steroidogenic factors, gonadotropin receptors, and IGF system members in small antral follicles by using an in vitro two-cell system that involved coculturing bovine GCs and theca cells (TCs) on a collagen membrane (Supplemental Fig. 1A ) (22, 23) . By explaining how the addition of rLH to ART cycles improves the ongoing pregnancy rate in women with POR, this research has basic and practical implications.
Materials and Methods

Materials
All culture media and supplements were purchased from Thermo Fisher Scientific (Kanagawa, Japan). Recombinant human FSH, LH, and human chorionic gonadotropin (hCG) were obtained from the National Hormone and Peptide Program, Harbor-UCLA Medical Center (Torrance, CA). Type 1 collagen membranes were obtained from Koken (Tokyo, Japan). For TC preparation, collagenase (type 1), DNase, BSA, and pancreatin were purchased from Sigma-Aldrich (St. Louis, MO). E2, DHT, IGF-1, flutamide [an androgen receptor (AR) antagonist], fulvestrant [an estrogen receptor (ESR) antagonist], Hoechst 33258 compound, and 3-isobutyl-1-methylxanthine (IBMX; a phosphodiesterase inhibitor) were also purchased from Sigma-Aldrich. Anti-IGF-1 receptor (IGF1R) antibody (aIR3; RRID: AB_10863579) was obtained from Abcam (catalog no. ab106836; Cambridge, United Kingdom). C8 ceramide (an inducer of cell cycle arrest and apoptosis) was purchased from Enzo Life Sciences (Farmingdale, NY). The Cell Proliferation Kit I (MTT) was obtained from Roche Applied Science (Mannheim, Germany). The Apoptosis Ladder Detection kit was purchased from Wako Pure Chemical Industries (Osaka, Japan). Enzyme immunoassay (EIA) kits for E2, testosterone, and cAMP were purchased from Cayman Chemical (Ann Arbor, MI). The bovine IGF-1 EIA kit was obtained from CUSABIO Biotech (College Park, MD). The Power SYBR Green Cells-to-C T Kit was purchased from Thermo Fisher Scientific (Waltham, MA). PCR primers were obtained from Eurofins Genomics (Tokyo, Japan).
Preparations and culture of GCs and TCs
This study was conducted in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals following protocols approved by the University of Fukui Committee on Animal Care.
In this study, bovine ovaries with a regressing corpus luteum were collected from adult, cycling heifers at a local abattoir and were transported to the laboratory in an ice-cold buffered salt solution. Bovine GCs and TCs were collected from small antral follicles (3 to 5 mm in diameter). This follicle size was selected because these small antral follicles are most relevant to the start of antral follicle growth during the follicular phase (24) . In particular, the mRNA of aromatase and LHR are first expressed in bovine GCs of follicles 4 to 6 mm and 8 to 9 mm in diameter, respectively (25) . GCs were harvested from follicles using aseptic needle aspiration and were washed three times. Washed GCs were filtered through a cell strainer (80 mm) and resuspended in a culture medium consisting of DMEM/Ham F-12 nutrient medium (Ham F-12) and 10% fetal calf serum (FCS; 6: 3:1 v/v/v) supplemented with streptomycin (100 mg/mL) and penicillin (100 U/mL). GC viability was estimated at 30% to 40% using trypan blue exclusion testing. For TC preparation, follicles with clear surfaces were cut into halves, and the theca interna layer was removed with fine forceps. GCs were removed by scraping with a scalpel under stereomicroscopy. The remaining TC layer was minced and dissociated into isolated cells by incubation with a Hanks-HEPES buffer containing collagenase (2150 U/mL), DNase (100 U/mL), and BSA (0.4% v/v) for 45 minutes, and subsequently with pancreatin (0.25% w/v) in Hanks-HEPES buffer for 7 minutes. Dispersed TCs were filtered through a cell strainer (80 mm) and washed three times in a culture medium consisting of DMEM/Ham F-12 and 10% FCS supplemented with streptomycin and penicillin. TC viability, which was estimated by trypan blue exclusion, was 90% to 95%. GCs (2 3 10 5 viable cells) and TCs (2 3 10 5 viable cells) were preincubated in a collagen-coated 48-well plate overnight in 1 mL of serum-free DMEM/Ham F-12 supplemented with streptomycin and penicillin to allow for GC and TC attachment. GCs and TCs were subsequently cultured for another 1 or 2 days under various treatments. The culture medium was changed every day. Our preliminary experiments indicated that 40% to 60% of GCs and 60% to 80% of TCs attached to the collagen-coated plate. Neither GCs nor TCs proliferate under the culture in the present serum-free system. Cultured GCs and TCs were removed by Accutase (Innovative Cell Technologies, San Diego, CA) according to the manufacturer's instructions and were stored at -80°C pending analysis.
Coculture of GCs and TCs on a collagen membrane
To more precisely explore the roles of FSH and LH in the maturation of ovarian follicles, we used an in vitro two-cell system that involved coculturing GCs and TCs on a collagen membrane (Supplemental Fig. 1A ) (22, 23) . This in vitro twocell system is designed to mimic the in vivo ovarian cellular environment. The cocultured cells have morphological and functional characteristics (e.g., proliferation, differentiation, and apoptosis) similar to those of follicular cells in vivo (22, 24, 26, 27) . The membrane (thickness, 70 mm) was made of type 1 collagen and had an area of 8 cm 2 . A supporting apparatus, to which the membrane was attached, was placed in a 6-cm plastic dish. Apical and basal chambers were separated, and the collagen membrane was permeable to materials with molecular weight (MW) ,12,500. For instance, testosterone (MW, 288), E2 (MW, 272), IGF-1 (MW, 7650), and IGF-2 (MW 7471) could pass through the collagen membrane, whereas FSH (MW, 37,000), LH (MW, 28,800), and inhibin (MW, 32,000) could not.
TCs (5 3 10 5 viable cells) were precultured on a collagen membrane for 3 hours in 1 mL of culture medium consisting of DMEM/Ham F-12 and 10% FCS supplemented with streptomycin and penicillin to allow for TC attachment. The membrane was then turned over and transferred into serum-free DMEM/Ham F-12. Freshly prepared GCs (5 3 10 5 viable cells) were cultured on the opposite side of the membrane overnight in 1 mL of serum-free DMEM/Ham F-12 for GC attachment. The medium and unattached cells (;30% to 50% of GCs and 40% to 60% of TCs) were removed, and then the attached GCs and TCs were cultured with different concentrations of FSH or LH for another 1 or 2 days (Supplemental Fig. 1B-1E ). The culture medium was changed every day. Cultured GCs were removed by Accutase and were stored at -80°C pending analysis.
Steroids and IGF-1 assays
Levels of E2, testosterone, and IGF-1 in the spent media were measured using the respective EIA kits already described, according to the manufacturers' instructions. The intra-assay coefficients of variation for E2, testosterone, and IGF-1 were 7.8%, 6.6%, and ,15%, respectively, whereas the interassay coefficients of variation for these assays were 8.2%, 7.5%, and ,15%, respectively. The sensitivities of the E2, testosterone, and IGF-1 assays were 15 pg/mL, 6 pg/mL, and 0.94 ng/mL, respectively.
RT-PCR analyses
Total RNAs from cultured GCs or TCs were extracted and reverse transcribed using the Power SYBR Green Cells-to-C T Kit, according to the manufacturer's protocol. Real-time quantitative PCR analyses of the genes encoding bovine aromatase (CYP19A1), FSH receptor (FSHR), LHR (LHR), IGF-1 (IGF1), IGF-2 (IGF2), IGF-1R (IGF1R), AR (AR), ESR1 (ESR1), ESR2 (ESR2), progesterone receptor (PGR), PGR membrane component (PGRMC) 1 (PGRMC1), PGRMC2, and acidic ribosomal phosphoprotein (ARBP; as an internal control) were performed on total RNAs from cultured GCs, using the specific primers indicated in Supplemental Table 1 . In addition, RT-PCR analyses of the genes encoding bovine steroidogenic acute regulatory protein (STAR), cholesterol side-chain cleavage cytochrome P450 (CYP11A1), and 17 a-hydroxylase/C17-20 lyase (CYP17A1), as well as LHR, IGF1, IGF2, IGF1R, and ARBP (internal control) were performed on total RNAs from cultured TCs, using the specific primers listed in Supplemental Table 1 . RT-PCR was performed using the StepOnePlus system (Applied Biosystems, Foster City, CA) with the following thermal cycling conditions: initial denaturation at 95°C for 10 minutes, followed by 40 cycles of 95°C for 15 seconds and 60°C for 1 minute. The relative mRNA expression of each target gene was normalized to that of ARBP.
cAMP assays
A functional analysis of the LHR in cultured GCs was performed by measuring intracellular cAMP levels after hCG challenge. The cultured GCs on the collagen membrane were washed in serum-free medium and were then preincubated with 1.0 mM IBMX for 1 hour at 37°C to prevent the breakdown of cAMP. Then, 0, 0.1, or 1 mg/mL hCG was added to the GCs and further incubated for 30 minutes at 37°C. The medium was then removed, and the GCs were extracted with 0.1 M hydrochloric acid. Intracellular cAMP levels were determined using the cAMP EIA kit after an acetylation procedure, in accordance with the manufacturer's instructions.
Analyses of GC apoptosis
To determine whether FSH and LH have an antiapoptotic effect on GCs, GCs were cultured on the collagen membrane with different concentrations of FSH or LH (0 to 100 ng/mL) and C8 ceramide (an inducer of cell cycle arrest and apoptosis; 30 mM, added 24 hours after FSH or LH) for 4 days. At the end of the culture period, floating cells and cells attached to the membrane were pooled and stained with Hoechst staining buffer (62.5 mg/mL in 10% formalin) overnight at 4°C. Apoptotic cells were identified on the basis of the typical apoptotic nuclear morphology (e.g., nuclear fragmentation, presence of apoptotic bodies) under fluorescent microscope, as previously reported (28) . At least 200 cells in a randomly selected area were assessed in each treatment group. To avoid experimental bias, the counter was not aware of the treatment. GC apoptosis was also assessed using a DNA ladder detection kit in accordance with the manufacturer's instructions. Furthermore, GCs were cultured in a collagen-coated 48-well plate for 4 days with various treatments, and the GC viability was determined using an MTT assay according to the manufacturer's protocol.
Statistical analysis
Results are presented as means 6 SEM of at least three independent experiments. All data were subjected to one-way ANOVA, except for the data recorded on LH stimulation of TCs for FSH sensitivity in GCs in the in vitro two-cell system, which were analyzed with an unpaired t test (Prism, version 4.03, and InStat, version 3.0; GraphPad Software, San Diego, CA). Differences between experimental groups were determined using the Tukey post hoc test. Statistical significance was inferred at P , 0.05.
Results
Effects of FSH and LH on follicle cell maturation in monolayer culture
In the monolayer culture with different concentrations of FSH or LH, FSH did not alter the mRNA levels of CYP19A1, FSHR, LHR, IGF1, IGF2, or IGF1R in GCs at days 1 and 2 of culture (Table 1 ). In contrast, LH decreased the mRNA levels of CYP19A1, LHR, and IGF1 in GCs, whereas it increased IGF1R mRNA levels in GCs at day 2 (Table 1) . Conversely, LH increased the mRNA expression of STAR, CYP11A1, CYP17A1, IGF1, and IGF1R in TCs at day 2 (Table 1; Fig. 1A ). LH also increased testosterone production in TCs at day 2 (Fig. 1B) . These results indicate that LH promotes androgen production and activates the IGF system in TCs.
To determine the roles of androgen and IGF-1 in LHinduced gene expression changes in TCs, TCs were cultured in the absence and presence of LH and/or flutamide (an AR antagonist) and anti-IGF-1R antibody (aIR3). Although LH induced the upregulation of CYP17A1 and IGF1 expression in TCs, administration of an AR antagonist, not aIR3, to the culture medium suppressed these responses (Fig. 1C) . This result indicates that the LH-induced androgen production and activation Data are given as means 6 SEM. The relative mRNA expression of each target gene in GCs or TCs was normalized to that of ARBP. a P , 0.01 vs without stimulation (0 ng/mL).
b P , 0.05 vs without stimulation (0 ng/mL). of the IGF system in TCs are mediated by androgen, not IGF-1.
Effects of FSH and LH on follicle cell maturation in in vitro two-cell system
In the presence of TCs in the in vitro two-cell system, FSH stimulation of GCs (Supplemental Fig. 1B) induced the mRNA expression of CYP19A1 and LHR in GCs at day 1 (Table 2 ; Fig. 2A) ; this induction effect was not observed at day 2 (data not shown). FSH stimulation of GCs also induced the mRNA expression of IGF1 and IGF2 in GCs at day 2 ( Table 2 ; Fig. 2A ). This is in contrast to the observation that FSH did not increase the mRNA levels of IGF1, IGF2, or IGF1R in GC monolayer culture (Table 1 ). These results demonstrate that TCs are required for the activation of the IGF system in GCs. In this system, LH stimulation of GCs (Supplemental Fig. 1C ) did not alter the mRNA levels of CYP19A1, FSHR, LHR, IGF1, IGF2, or IGF1R in GCs during the 2-day culture (Table 2) . However, LH stimulation of TCs (Supplemental Fig. 1D ) induced the mRNA expression of CYP19A1, LHR, and IGF1 in GCs at day 2, in a paracrine manner (Table 2; Fig. 2B ). FSH stimulation of GCs (Fig. 3A) and LH stimulation of TCs (Fig. 3B) , but not LH stimulation of GCs (data not shown), increased the concentrations of E2 and IGF-1 in GCs spent media at day 2. These results indicate that FSH and LH are involved in increasing the capacity for E2 production and the activation of the IGF system in follicular maturation.
LH stimulation of TCs induced functional LHR expression in GCs
LH stimulation of TCs in the GC-TC coculture significantly increased hCG-induced cAMP accumulation in GCs (Fig. 4A) , indicating that LH stimulation of TCs induced functional LHR expression in GCs.
Although LH stimulation of TCs induced LHR and aromatase expression in GCs, the addition of an AR antagonist and an ESR antagonist to the GC culture medium suppressed these responses, suggesting that the LH-induced thecal paracrine signal is androgen or estrogen ( Fig. 4B and 4C) . Moreover, we found that 10 mM E2, but not DHT or IGF-1, increased LHR and CYP19A1 mRNA levels in GCs (Fig. 4D and 4E) . These results indicate that expression of granulosal LHR and aromatase expression induced by LH stimulation of TCs are mediated by estrogen, not androgen or IGF-1.
LH stimulation of TCs induced ESR1 and ESR2 expression in GCs ( Table 3 ), indicating that LH stimulation of TCs increased estrogen sensitivity in small antral follicles. In contrast, LH stimulation of TCs did not alter the mRNA levels of PGR, PGRMC1, or PGRMC2 in GCs ( Table 3 ), demonstrating that the cultured GCs were not luteinized and retained their small antral follicle characters in the in vitro twocell system.
LH stimulation of TCs protected GCs from ceramide-induced apoptosis
Treatment with C8 ceramide significantly increased apoptosis in GCs (Fig. 5A and 5B). This was significantly attenuated by LH stimulation of TCs (Fig. 5B) but not by FSH stimulation of GCs (Fig. 5A) . LH stimulation of TCs also suppressed DNA laddering in GCs (Fig. 5C ). These findings demonstrate that LH stimulation of TCs protects GCs from ceramide-induced apoptosis. Although LH stimulation of TCs suppressed ceramide-induced apoptosis in GCs, the addition of aIR3 to the GC culture medium attenuated this response (Fig. 6A) . Furthermore, IGF-1 significantly suppressed ceramide-induced apoptosis in GCs, whereas DHT, E2, FSH, and LH did not affect GC apoptosis (Fig. 6B) . In monolayer culture, IGF-1 and FSH significantly increased GC viability (Fig. 6C) . These findings indicate that thecal IGF-1 induced by LH stimulation suppresses GC apoptosis.
LH stimulation of TCs increased FSH sensitivity in GCs in in vitro two-cell system
Without LH stimulation of TCs, 10 ng/mL FSH did not alter the mRNA levels of FSHR, LHR, or CYP19A1 in GCs (Fig. 7A) . Conversely, with LH stimulation of TCs, a low dose of FSH increased the mRNA expression of FSHR, LHR, and CYP19A1 in GCs (Fig. 7B) . These results indicate that LH stimulation of TCs increases FSH sensitivity in GCs in a paracrine manner.
Discussion
In this study, we have demonstrated that LH stimulation of TCs promoted androgen production in TCs by inducing the expression of androgenic factors (i.e., STAR, CYP11A1, and CYP17A1) and subsequently increasing estrogen biosynthesis in GCs by providing androgen substrate and inducing aromatase expression in bovine small antral follicles. LH stimulation of TCs induced functional LHR expression in GCs, a response attenuated by a specific ESR antagonist. In the presence of TCs, LH stimulation of TCs and FSH stimulation of GCs activated the IGF system (i.e., IGF-1, IGF-2, and IGF-1R) in GCs. LH-induced thecal IGF-1 protected GCs from apoptosis and promoted GC survival. These results suggest that the LH-TC axis is involved in the acquisition of LH dependence and the survival of small antral follicles during the follicular phase by upregulating androgen/estrogen biosynthesis and activating the IGF system (Fig. 8) .
It has been shown that the induction of aromatase and LHR expression in GCs is mainly regulated by FSH (29) . E2 and IGF-1 enhance various FSH functions in GCs, including aromatase and LHR induction (30) (31) (32) (33) . In our in vitro system, however, the stimulatory effect of FSH on CYP19A1 and LHR expression in GCs persisted for only 24 hours. Conversely, LH stimulation of TCs induced aromatase expression and increased E2 and IGF-1 biosynthesis in GCs. LH stimulation of TCs also induced LHR expression in GCs in a paracrine manner. A specific ESR antagonist suppressed the granulosal CYP19A1 and LHR expression induced by LH stimulation of TCs. In monolayer culture, E2 directly increased CYP19A1 and LHR levels in GCs. These results suggest that the aromatase and LHR expression in GCs induced by the LH stimulation of TCs is mediated by the synthesis and action of estrogen and, therefore, is a phenomenon sensitive to ESR signaling and function. Thus, the LH-TC axis might facilitate follicular development and maturation by activating estrogen production during the human follicular phase. In the in vitro two-cell system, LH stimulation of TCs increased the sensitivity of estrogen and FSH in GCs of small antral follicles. E2 is required for the FSH action in GCs (34) (35) (36) . Therefore, the addition of rLH to COS may activate local estrogen biosynthesis in antral follicles and augment follicular sensitivity to gonadotropins, resulting in better ovarian responses to COS, even in patients with POR. During the human follicular phase, LH stimulates androgen production in TCs. Evidence suggests that the thecal androgens have a growth-promoting effect in early folliculogenesis (37) (38) (39) (40) . In humans, supplementation with an adrenal-derived androgen dehydroepiandrosterone is effective in ovulation induction in patients with POR (41) . Human menopausal gonadotropins, which include LH and FSH, are more effective than rFSH in COS in older infertile women (42) . Moreover, treatment of rhesus monkeys with androgens increases the abundance of FSHR mRNA in GCs and increases the growth of preantral and small antral follicles (38, 43 ). In the current study, LH stimulation of TCs increased androgen production in TCs and FSH sensitivity in GCs of small antral follicles. These findings suggest that androgen also increases follicular sensitivity to FSH, thereby augmenting the growth of small antral follicles. Although FSHR expression in GCs is significantly reduced during the human follicular phase (15) , local androgen may function to maintain FSH sensitivity in antral follicles.
IGF-1 and IGF-2 signal through IGF-1R and control cell growth and survival in GCs (44) (45) (46) . Female IGF-1 knockout mice are infertile because their follicle growth arrests in the early antral stage, indicating that an active IGF system is required for follicular maturation (47) . Although circulating IGF-2 levels in serum do not change throughout the human menstrual cycle, IGF-2 levels in follicular fluid are elevated during follicular maturation (19) , suggesting that gonadotropins activate the local IGF system in ovarian follicles. FSH does not increase IGF-1 levels in rodent GCs and bovine GCs (45, 48, 49) , whereas FSH induces IGF-2 expression in human GCs (50) . In our in vitro system, LH stimulation of TCs induced IGF-1 production in TCs and GCs. In the presence of TCs, FSH also stimulated IGF-1 and IGF-2 expression in GCs. Thecal IGF-1 suppressed GC apoptosis and promoted GC survival. These results suggest that the In an in vitro two-cell system, TCs were cultured in the (A) absence and (B) presence of LH (100 ng/mL). Simultaneously, GCs were stimulated with 10 ng/mL FSH for 1 day. mRNA levels of FSHR, LHR, and CYP19A1 were analyzed in the cultured GCs. The relative mRNA expression (RE) of each target gene was normalized to that of ARBP. LH stimulation of TCs increased FSH sensitivity in GCs in a paracrine manner. *P , 0.05. D1, day 1 of culture.
LH-TC axis facilitates follicular development and survival by activating the local IGF system in GCs and TCs during the follicular phase. The addition of rLH to COS may thus activate the local IGF system in antral follicles and promote follicular survival and growth by suppressing GC apoptosis and follicular atresia, resulting in multiple follicular development and maturation, even in patients with POR.
Substantial differences in the ovarian IGF system exist among various species. For instance, rodent GCs produce mostly IGF-1 (51), whereas bovine GCs and TCs produce both IGF-1 and IGF-2 (49, 52) . In humans, IGF-1 is only expressed in TCs of small antral follicles, whereas IGF-2 is abundantly expressed in GCs and TCs of the dominant follicles, suggesting that IGF-2 is more important during human follicular maturation (50, 53) . Although IGF-1 is expressed in TCs and IGF-1R is expressed in GCs of human small antral follicles, additional studies are required to determine whether the present finding (i.e., suppression of GC apoptosis by thecal IGF) can be translated to humans.
In summary, our results indicate that LH begins to influence follicular development as early as the small antral stage. LH stimulates androgen production in TCs and, subsequently, estrogen production in GCs, inducing LHR expression in GCs and follicular maturation.
LH also activates the IGF system in antral follicles, suppressing GC apoptosis and follicular atresia. These findings may explain the beneficial effect of rLH on COS in patients with POR. Clinical studies are required to determine the optimal protocol of LH supplementation, allowing for more individually tailored treatments and improved ART outcomes.
